(photo: Alan Levine/public domain) Drugmaker Eli Lilly and Company announced price reductions for many of its insulin products as well as a $35 monthly cap for what patients pay out of their own pockets for insulin. Continue reading “Eli Lilly Announces Price Reductions & Monthly Cap For Insulin”